Omega Flex Reports Q2 2026 Results; CE Mark for MediTrac Tubing

What Happened
Omega Flex, Inc. (OFLX) filed an 8-K on August 12, 2026 announcing its reported results for the three- and six-month periods ended June 30, 2026 and disclosing CE Mark approval for its MediTrac® corrugated medical tubing. The company issued a press release covering these items, which is attached as Exhibit 99.1 to the filing.

Key Details

• Filing date: August 12, 2026; press release attached as Exhibit 99.1.
• Periods reported: results for the three months and six months ended June 30, 2026.
• Regulatory update: CE Mark approval granted for MediTrac® corrugated medical tubing (enables marketing in the European Economic Area).
• Financial disclosure item: reported under Item 2.02 (Results of Operations and Financial Condition).

Why It Matters
The 8-K provides investors with Omega Flex’s latest quarterly financial results and a regulatory milestone for its medical-products line. The CE Mark for MediTrac means the product meets EU requirements for sale there, which could expand commercial opportunities for the company’s medical tubing business. Investors should review the attached press release (Exhibit 99.1) for the detailed financial figures and any management commentary.